Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.09
+0.03 (0.59%)
Apr 29, 2026, 1:36 PM EDT - Market open
Protara Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 275 | 286 | 253 | 21 | 30 | 76 | |
| Market Cap Growth | 91.49% | 12.67% | 1089.52% | -29.43% | -60.18% | -72.06% | |
| Enterprise Value | 79 | 156 | 177 | -47 | -70 | -55 | |
| Last Close Price | 5.06 | 5.33 | 5.28 | 1.88 | 2.68 | 6.75 | |
| PB Ratio | 1.38 | 1.45 | 1.52 | 0.31 | 0.30 | 0.47 | |
| P/TBV Ratio | 1.39 | 1.45 | 1.52 | 0.31 | 0.30 | 0.57 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.08 | 0.06 | 0.05 | |
| Net Debt / Equity Ratio | -0.99 | -0.99 | -0.99 | -0.88 | -0.94 | -0.76 | |
| Net Debt / EBITDA Ratio | 3.03 | 3.03 | 3.40 | 1.39 | 2.57 | 2.61 | |
| Net Debt / FCF Ratio | 3.45 | 3.45 | 4.62 | 1.60 | 3.61 | 3.52 | |
| Quick Ratio | 14.34 | 14.34 | 15.54 | 10.71 | 14.78 | 21.37 | |
| Current Ratio | 14.58 | 14.58 | 15.71 | 11.17 | 15.01 | 21.66 | |
| Return on Equity (ROE) | -31.60% | -31.60% | -37.88% | -47.44% | -49.96% | -26.17% | |
| Return on Assets (ROA) | -20.64% | -20.64% | -23.59% | -28.36% | -16.42% | -15.80% | |
| Return on Capital Employed (ROCE) | -32.50% | -32.50% | -28.80% | -59.90% | -34.90% | -28.20% | |
| Earnings Yield | -20.99% | -20.11% | -17.59% | -189.67% | -218.41% | -62.30% | |
| FCF Yield | -20.63% | -19.77% | -14.15% | -176.45% | -88.01% | -46.28% | |
| Buyback Yield / Dilution | -108.02% | -108.02% | -81.73% | -0.64% | -0.24% | -55.28% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.